Larsen F S, Gottstein J, Blei A T
Department of Medicine, Chicago VA Healthcare System, Northwestern University, Chicago, Illinois, USA.
J Hepatol. 2001 Apr;34(4):548-54. doi: 10.1016/s0168-8278(00)00069-6.
BACKGROUND/AIM: Brain edema is a common fatal complication in acute liver failure. It is related to an acute change in brain osmolarity secondary to the glial accumulation of glutamine. Since high cerebral blood flow (CBF) precedes cerebral herniation in fulminant hepatic failure we first determined if an increase in brain water and glutamine are prerequisite to a rise in CBF in a model of ammonia-induced brain edema. Secondly, we determined if such a cerebral hyperperfusion is mediated by nitric oxide synthase (NOS).
Male rats received an end-to-side portacaval anastomosis (PCA). At 24 h, they were anesthetized with ketamine and infused with ammonium acetate (55 microM/kg per min). Studies were performed at 60, 90, 120, 150 and 180 min after starting the ammonia infusion and once the intracranial pressure had risen three-fold (mean 210'). Brain water (BW) was measured using the gravimetry method and CBF with the radioactive microsphere technique. Glutamine (GLN) in the CSF was sampled via a cisterna magna catheter. The neuronal NOS was specifically inhibited by 1-2-trifluoromethylphenyl imidazole (TRIM, 50 mg/kg intraperitoneally) and in separate studies nonspecifically by N-omega-nitro-L-arginine (L-NNA, 2 microg/kg per min intravenously)
At 90', brain water was significantly increased (P < 0.015) as compared to the 60' group while CBF was significantly different at 150'. A significant correlation was observed between values of CBF and brain water (r = 0.88, n = 36, P < 0.001). Administration of either TRIM or L-NNA did not prevent the development of cerebral hyperperfu. sion and edema.
We observed that cerebral hyperemia follows an initial rise in brain water content, rather than in the cerebrospinal fluid concentration of glutamine. The rise in CBF further correlated with brain water accumulation and was of critical importance for the development of intracranial hypertension. The unique mechanism for the rise in CBF in hyperammonemia was not prevented by NOS inhibition indicating that NO is not the mediator of high CBF and intracranial hypertension.
背景/目的:脑水肿是急性肝衰竭常见的致命并发症。它与谷氨酰胺在胶质细胞中蓄积继发的脑渗透压急性变化有关。由于在暴发性肝衰竭中脑血流(CBF)增加先于脑疝形成,我们首先在氨诱导的脑水肿模型中确定脑含水量和谷氨酰胺增加是否是CBF升高的先决条件。其次,我们确定这种脑血流灌注过多是否由一氧化氮合酶(NOS)介导。
雄性大鼠接受端侧门腔静脉吻合术(PCA)。24小时后,用氯胺酮麻醉,然后输注醋酸铵(55微摩尔/千克每分钟)。在开始输注氨后60、90、120、150和180分钟以及颅内压升高至三倍时(平均210')进行研究。采用重量法测量脑含水量(BW),用放射性微球技术测量CBF。通过枕大池导管采集脑脊液中的谷氨酰胺(GLN)。用1-2-三氟甲基苯基咪唑(TRIM,50毫克/千克腹腔注射)特异性抑制神经元NOS,在单独的研究中用N-ω-硝基-L-精氨酸(L-NNA,2微克/千克每分钟静脉注射)非特异性抑制。
与60分钟组相比,90分钟时脑含水量显著增加(P<0.015),而CBF在150分钟时显著不同。观察到CBF值与脑含水量之间存在显著相关性(r = 0.88,n = 36,P<0.001)。给予TRIM或L-NNA均不能阻止脑血流灌注过多和水肿的发展。
我们观察到脑充血发生在脑含水量最初升高之后,而不是脑脊液中谷氨酰胺浓度升高之后。CBF升高与脑含水量增加进一步相关,对颅内高压的发展至关重要。NOS抑制不能阻止高氨血症中CBF升高的独特机制,表明NO不是高CBF和颅内高压的介质。